# The Rostral Ventrolateral Medulla Input to Central Amygdala Regulates Anxiety‐Like Behaviors in Mice for Chronic Light Exposure

**Authors:** Jia‐Ni Jing, Xing Tan, Chou Xu, Chao Yuan, Hao Fan, Wei‐Zhong Wang

PMC · DOI: 10.1002/cns.70775 · CNS Neuroscience & Therapeutics · 2026-02-05

## TL;DR

Chronic light exposure increases anxiety in mice by enhancing brain activity in a specific neural pathway involving the RVLM and CeA.

## Contribution

The study identifies a novel RVLM→CeA circuit that regulates anxiety-like behaviors caused by chronic light exposure.

## Key findings

- Chronic light exposure elevates blood pressure and neuronal activity, especially in the RVLM.
- Inhibiting the RVLM→CeA pathway reduces anxiety-like behaviors in mice exposed to chronic light.
- Optogenetic activation of the RVLM→CeA pathway in normal mice induces anxiety-like behaviors.

## Abstract

Emerging evidence increasingly links environmental light exposure to the development of anxiety disorder. The rostral ventrolateral medulla (RVLM), a key brainstem center that regulates sympathetic outflow and blood pressure (BP), has been implicated in the autonomic dysregulation frequently observed in anxiety. High blood pressure is a recognized exacerbating factor for anxiety‐related pathology. Although aberrant projections from the central amygdala (CeA) to brainstem regions have been reported in multiple mood disorders, it remains unclear whether the CeA receives input from the RVLM and to what extent the RVLM's excitation influences anxiety symptoms induced by chronic light exposure (CL).

We employed a chronic mild light (250–300 lx) for 4 weeks to induce anxiety‐like behaviors in mice. Using a tail‐cuff system and ELISA assay, we assessed CL mice's BP and plasma catecholamine levels. Immunofluorescence was utilized to unravel the neuronal c‐fos expression in the RVLM and CeA. Combining retrograde virus tracing technology, chemogenetic and optogenetic manipulations in freely moving mice to examine the effects of regulating RVLM‐CeA pathway on anxiety‐like behaviors induced by chronic light.

Chronic light exposure in mice induces elevated blood pressure and elevated neuronal activity, which are more pronounced in the RVLM than in the CeA. Chemogenetic inhibition of RVLM neurons markedly attenuated CL‐induced anxiety‐like behaviors. Moreover, optogenetic inhibition of the RVLM→CeA pathway reduced anxiety phenotypes in CL‐exposed mice, whereas optogenetic activation of this pathway in normal mice acutely triggered anxiety‐like behaviors.

These findings demonstrate that the enhanced excitatory signaling within the RVLM→CeA circuit underlies the development of anxiety‐like behaviors induced by chronic light, revealing a novel mechanism by which the RVLM regulates light‐related affective dysfunction.

Jing et al. demonstrate that the CeA receives input from the RVLM in normal mice, and the chronic light exposure induced more pronounced elevated neuronal activity in the RVLM than the CeA. The enhanced excitatory input from the RVLM to CeA induced anxiety‐like behaviors in mice, revealing a novel circuit by which the RVLM regulates light‐related anxiety dysfunction.

## Linked entities

- **Diseases:** anxiety disorder (MONDO:0005618)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Th (tyrosine hydroxylase) [NCBI Gene 21823], Cea (carcinoembryonic antigen gene family) [NCBI Gene 111518], Fos (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 14281] {aka D12Rfj1, c-fos, cFos}
- **Diseases:** hyperactivity (MESH:D006948), CL (MESH:D020795), cerebral hypoperfusion (MESH:D002547), elevated blood (MESH:D006402), hypertension (MESH:D006973), psychiatric (MESH:D001523), myocardial infarction (MESH:D009203), Anxiety (MESH:D001007), inflammation (MESH:D007249), affective (MESH:D019964), metabolic syndrome (MESH:D024821), glucocorticoid resistance (MESH:C564221), depression (MESH:D003866), cardiovascular disease (MESH:D002318), anhedonia (MESH:D059445), emotional dysregulation (MESH:D021081), anxiety disorder (MESH:D001008)
- **Chemicals:** TBS (MESH:D013725), melatonin (MESH:D008550), CL (-), catecholamine (MESH:D002395), epinephrine (MESH:D004837), sugar (MESH:D000073893), pentobarbital sodium (MESH:D010424), isoflurane (MESH:D007530), water (MESH:D014867), norepinephrine (MESH:D009638), Hoechst 33342 (MESH:C017807), DBP (MESH:D004145), corticosterone (MESH:D003345), ethanol (MESH:D000431), PFA (MESH:C003043), Triton X-100 (MESH:D017830), CNO (MESH:C079149), sucrose (MESH:D013395), glycerol (MESH:D005990)
- **Species:** adeno-associated virus 2 (no rank) [taxon 10804], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** C-25 C

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12877313/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12877313/full.md

## References

55 references — full list in the complete paper: https://tomesphere.com/paper/PMC12877313/full.md

---
Source: https://tomesphere.com/paper/PMC12877313